POST-THYROIDECTOMY THYROTOXICOSIS
Identifieur interne : 000E22 ( Istex/Corpus ); précédent : 000E21; suivant : 000E23POST-THYROIDECTOMY THYROTOXICOSIS
Auteurs : W. J. Kalk ; Shirley Kantor ; D. Durbach ; J. LevinSource :
- The Lancet [ 0140-6736 ] ; 1978.
English descriptors
- Teeft :
- Archs surg, Early recurrences, Euthyroid, Euthyroid patients, Goitre, Goitre size, Goitre weight, Hyperthyroidism, Hypothyroid, Hypothyroidism, Influenza, Johannesburg hospital, Large remnants, Moderate epidemic, Permanent hypothyroidism, Postoperative, Radioiodine, Radioiodine therapy, Recurrence, Recurrent, Recurrent goitres, Recurrent hyperthyroidism, Recurrent thyrotoxicosis, Remnant, Significant incidence, Surg, Therapeutic dose, Thyroid function, Thyroid remnants, Thyroid scan, Thyrotoxicosis, True incidence, Years postoperatively, Young adults.
Abstract
Abstract: 94 patients with postoperative recurrent hyperthyroidism were evaluated for duration of remission, goitre size, and response to radio-iodine (131I). 6 patients required 131I therapy within twelve months of operation—5 had large remnants because of inadequate surgery. 57% of patients relapsed within 5 years, but 16% relapsed after 20 years and 8% after more than 30 years. Estimated goitre weights ranged from 4 g to 65 g, and goitre size was unrelated to the duration of remission. All patients were treated with 131I. 23% of the patients became hypothyroid in the first postoperative year and 10% in the second year. The results indicate that postoperative thyrotoxicosis can recur decades after operation. Operation seems to sensitise the thyroid to the early effects of radiation by 131I.
Url:
DOI: 10.1016/S0140-6736(78)90067-3
Links to Exploration step
ISTEX:7EB41D1F2A9F1C85E627B44432FA893096270488Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title>POST-THYROIDECTOMY THYROTOXICOSIS</title>
<author><name sortKey="Kalk, W J" sort="Kalk, W J" uniqKey="Kalk W" first="W. J." last="Kalk">W. J. Kalk</name>
<affiliation><mods:affiliation>Departments of Medicine, Radiotherapy, and Nuclear Medicine, University of the Witwatersrand and Johannesburg Hospital, Johannesburg, South Africa</mods:affiliation>
</affiliation>
</author>
<author><name sortKey="Kantor, Shirley" sort="Kantor, Shirley" uniqKey="Kantor S" first="Shirley" last="Kantor">Shirley Kantor</name>
<affiliation><mods:affiliation>Departments of Medicine, Radiotherapy, and Nuclear Medicine, University of the Witwatersrand and Johannesburg Hospital, Johannesburg, South Africa</mods:affiliation>
</affiliation>
</author>
<author><name sortKey="Durbach, D" sort="Durbach, D" uniqKey="Durbach D" first="D." last="Durbach">D. Durbach</name>
<affiliation><mods:affiliation>Departments of Medicine, Radiotherapy, and Nuclear Medicine, University of the Witwatersrand and Johannesburg Hospital, Johannesburg, South Africa</mods:affiliation>
</affiliation>
</author>
<author><name sortKey="Levin, J" sort="Levin, J" uniqKey="Levin J" first="J." last="Levin">J. Levin</name>
<affiliation><mods:affiliation>Departments of Medicine, Radiotherapy, and Nuclear Medicine, University of the Witwatersrand and Johannesburg Hospital, Johannesburg, South Africa</mods:affiliation>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:7EB41D1F2A9F1C85E627B44432FA893096270488</idno>
<date when="1978" year="1978">1978</date>
<idno type="doi">10.1016/S0140-6736(78)90067-3</idno>
<idno type="url">https://api.istex.fr/ark:/67375/6H6-M3NQZ9WX-2/fulltext.pdf</idno>
<idno type="wicri:Area/Istex/Corpus">000E22</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">000E22</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title level="a">POST-THYROIDECTOMY THYROTOXICOSIS</title>
<author><name sortKey="Kalk, W J" sort="Kalk, W J" uniqKey="Kalk W" first="W. J." last="Kalk">W. J. Kalk</name>
<affiliation><mods:affiliation>Departments of Medicine, Radiotherapy, and Nuclear Medicine, University of the Witwatersrand and Johannesburg Hospital, Johannesburg, South Africa</mods:affiliation>
</affiliation>
</author>
<author><name sortKey="Kantor, Shirley" sort="Kantor, Shirley" uniqKey="Kantor S" first="Shirley" last="Kantor">Shirley Kantor</name>
<affiliation><mods:affiliation>Departments of Medicine, Radiotherapy, and Nuclear Medicine, University of the Witwatersrand and Johannesburg Hospital, Johannesburg, South Africa</mods:affiliation>
</affiliation>
</author>
<author><name sortKey="Durbach, D" sort="Durbach, D" uniqKey="Durbach D" first="D." last="Durbach">D. Durbach</name>
<affiliation><mods:affiliation>Departments of Medicine, Radiotherapy, and Nuclear Medicine, University of the Witwatersrand and Johannesburg Hospital, Johannesburg, South Africa</mods:affiliation>
</affiliation>
</author>
<author><name sortKey="Levin, J" sort="Levin, J" uniqKey="Levin J" first="J." last="Levin">J. Levin</name>
<affiliation><mods:affiliation>Departments of Medicine, Radiotherapy, and Nuclear Medicine, University of the Witwatersrand and Johannesburg Hospital, Johannesburg, South Africa</mods:affiliation>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series><title level="j">The Lancet</title>
<title level="j" type="abbrev">LANCET</title>
<idno type="ISSN">0140-6736</idno>
<imprint><publisher>ELSEVIER</publisher>
<date type="published" when="1978">1978</date>
<biblScope unit="volume">311</biblScope>
<biblScope unit="issue">8059</biblScope>
<biblScope unit="page" from="291">291</biblScope>
<biblScope unit="page" to="294">294</biblScope>
</imprint>
<idno type="ISSN">0140-6736</idno>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><idno type="ISSN">0140-6736</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="Teeft" xml:lang="en"><term>Archs surg</term>
<term>Early recurrences</term>
<term>Euthyroid</term>
<term>Euthyroid patients</term>
<term>Goitre</term>
<term>Goitre size</term>
<term>Goitre weight</term>
<term>Hyperthyroidism</term>
<term>Hypothyroid</term>
<term>Hypothyroidism</term>
<term>Influenza</term>
<term>Johannesburg hospital</term>
<term>Large remnants</term>
<term>Moderate epidemic</term>
<term>Permanent hypothyroidism</term>
<term>Postoperative</term>
<term>Radioiodine</term>
<term>Radioiodine therapy</term>
<term>Recurrence</term>
<term>Recurrent</term>
<term>Recurrent goitres</term>
<term>Recurrent hyperthyroidism</term>
<term>Recurrent thyrotoxicosis</term>
<term>Remnant</term>
<term>Significant incidence</term>
<term>Surg</term>
<term>Therapeutic dose</term>
<term>Thyroid function</term>
<term>Thyroid remnants</term>
<term>Thyroid scan</term>
<term>Thyrotoxicosis</term>
<term>True incidence</term>
<term>Years postoperatively</term>
<term>Young adults</term>
</keywords>
</textClass>
<langUsage><language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Abstract: 94 patients with postoperative recurrent hyperthyroidism were evaluated for duration of remission, goitre size, and response to radio-iodine (131I). 6 patients required 131I therapy within twelve months of operation—5 had large remnants because of inadequate surgery. 57% of patients relapsed within 5 years, but 16% relapsed after 20 years and 8% after more than 30 years. Estimated goitre weights ranged from 4 g to 65 g, and goitre size was unrelated to the duration of remission. All patients were treated with 131I. 23% of the patients became hypothyroid in the first postoperative year and 10% in the second year. The results indicate that postoperative thyrotoxicosis can recur decades after operation. Operation seems to sensitise the thyroid to the early effects of radiation by 131I.</div>
</front>
</TEI>
<istex><corpusName>elsevier</corpusName>
<keywords><teeft><json:string>thyrotoxicosis</json:string>
<json:string>radioiodine</json:string>
<json:string>surg</json:string>
<json:string>hypothyroid</json:string>
<json:string>postoperative</json:string>
<json:string>recurrent thyrotoxicosis</json:string>
<json:string>hyperthyroidism</json:string>
<json:string>euthyroid</json:string>
<json:string>radioiodine therapy</json:string>
<json:string>recurrence</json:string>
<json:string>hypothyroidism</json:string>
<json:string>recurrent goitres</json:string>
<json:string>true incidence</json:string>
<json:string>euthyroid patients</json:string>
<json:string>therapeutic dose</json:string>
<json:string>thyroid scan</json:string>
<json:string>archs surg</json:string>
<json:string>remnant</json:string>
<json:string>recurrent</json:string>
<json:string>goitre</json:string>
<json:string>goitre size</json:string>
<json:string>recurrent hyperthyroidism</json:string>
<json:string>johannesburg hospital</json:string>
<json:string>young adults</json:string>
<json:string>permanent hypothyroidism</json:string>
<json:string>thyroid function</json:string>
<json:string>years postoperatively</json:string>
<json:string>significant incidence</json:string>
<json:string>goitre weight</json:string>
<json:string>early recurrences</json:string>
<json:string>large remnants</json:string>
<json:string>moderate epidemic</json:string>
<json:string>thyroid remnants</json:string>
<json:string>influenza</json:string>
</teeft>
</keywords>
<author><json:item><name>W.J. Kalk</name>
<affiliations><json:string>Departments of Medicine, Radiotherapy, and Nuclear Medicine, University of the Witwatersrand and Johannesburg Hospital, Johannesburg, South Africa</json:string>
</affiliations>
</json:item>
<json:item><name>Shirley Kantor</name>
<affiliations><json:string>Departments of Medicine, Radiotherapy, and Nuclear Medicine, University of the Witwatersrand and Johannesburg Hospital, Johannesburg, South Africa</json:string>
</affiliations>
</json:item>
<json:item><name>D. Durbach</name>
<affiliations><json:string>Departments of Medicine, Radiotherapy, and Nuclear Medicine, University of the Witwatersrand and Johannesburg Hospital, Johannesburg, South Africa</json:string>
</affiliations>
</json:item>
<json:item><name>J. Levin</name>
<affiliations><json:string>Departments of Medicine, Radiotherapy, and Nuclear Medicine, University of the Witwatersrand and Johannesburg Hospital, Johannesburg, South Africa</json:string>
</affiliations>
</json:item>
</author>
<arkIstex>ark:/67375/6H6-M3NQZ9WX-2</arkIstex>
<language><json:string>eng</json:string>
</language>
<originalGenre><json:string>Full-length article</json:string>
</originalGenre>
<abstract>Abstract: 94 patients with postoperative recurrent hyperthyroidism were evaluated for duration of remission, goitre size, and response to radio-iodine (131I). 6 patients required 131I therapy within twelve months of operation—5 had large remnants because of inadequate surgery. 57% of patients relapsed within 5 years, but 16% relapsed after 20 years and 8% after more than 30 years. Estimated goitre weights ranged from 4 g to 65 g, and goitre size was unrelated to the duration of remission. All patients were treated with 131I. 23% of the patients became hypothyroid in the first postoperative year and 10% in the second year. The results indicate that postoperative thyrotoxicosis can recur decades after operation. Operation seems to sensitise the thyroid to the early effects of radiation by 131I.</abstract>
<qualityIndicators><score>6.083</score>
<pdfWordCount>2583</pdfWordCount>
<pdfCharCount>15742</pdfCharCount>
<pdfVersion>1.2</pdfVersion>
<pdfPageCount>4</pdfPageCount>
<pdfPageSize>622 x 931 pts</pdfPageSize>
<refBibsNative>true</refBibsNative>
<abstractWordCount>125</abstractWordCount>
<abstractCharCount>803</abstractCharCount>
<keywordCount>0</keywordCount>
</qualityIndicators>
<title>POST-THYROIDECTOMY THYROTOXICOSIS</title>
<pmid><json:string>75333</json:string>
</pmid>
<pii><json:string>S0140-6736(78)90067-3</json:string>
</pii>
<genre><json:string>research-article</json:string>
</genre>
<host><title>The Lancet</title>
<language><json:string>unknown</json:string>
</language>
<publicationDate>1978</publicationDate>
<issn><json:string>0140-6736</json:string>
</issn>
<pii><json:string>S0140-6736(00)X2692-X</json:string>
</pii>
<volume>311</volume>
<issue>8059</issue>
<pages><first>291</first>
<last>294</last>
</pages>
<genre><json:string>journal</json:string>
</genre>
</host>
<namedEntities><unitex><date><json:string>1973</json:string>
<json:string>1978</json:string>
</date>
<geogName></geogName>
<orgName><json:string>Johannesburg Hospital, Johannesburg, South Africa</json:string>
</orgName>
<orgName_funder></orgName_funder>
<orgName_provider></orgName_provider>
<persName></persName>
<placeName><json:string>Britain</json:string>
</placeName>
<ref_url></ref_url>
<ref_bibl></ref_bibl>
<bibl></bibl>
</unitex>
</namedEntities>
<ark><json:string>ark:/67375/6H6-M3NQZ9WX-2</json:string>
</ark>
<categories><wos><json:string>1 - science</json:string>
<json:string>2 - medicine, general & internal</json:string>
</wos>
<scienceMetrix><json:string>1 - health sciences</json:string>
<json:string>2 - clinical medicine</json:string>
<json:string>3 - general & internal medicine</json:string>
</scienceMetrix>
<scopus><json:string>1 - Health Sciences</json:string>
<json:string>2 - Medicine</json:string>
<json:string>3 - General Medicine</json:string>
</scopus>
<inist><json:string>1 - sciences appliquees, technologies et medecines</json:string>
<json:string>2 - sciences biologiques et medicales</json:string>
<json:string>3 - sciences medicales</json:string>
</inist>
</categories>
<publicationDate>1978</publicationDate>
<copyrightDate>1978</copyrightDate>
<doi><json:string>10.1016/S0140-6736(78)90067-3</json:string>
</doi>
<id>7EB41D1F2A9F1C85E627B44432FA893096270488</id>
<score>1</score>
<fulltext><json:item><extension>pdf</extension>
<original>true</original>
<mimetype>application/pdf</mimetype>
<uri>https://api.istex.fr/ark:/67375/6H6-M3NQZ9WX-2/fulltext.pdf</uri>
</json:item>
<json:item><extension>zip</extension>
<original>false</original>
<mimetype>application/zip</mimetype>
<uri>https://api.istex.fr/ark:/67375/6H6-M3NQZ9WX-2/bundle.zip</uri>
</json:item>
<istex:fulltextTEI uri="https://api.istex.fr/ark:/67375/6H6-M3NQZ9WX-2/fulltext.tei"><teiHeader><fileDesc><titleStmt><title level="a">POST-THYROIDECTOMY THYROTOXICOSIS</title>
</titleStmt>
<publicationStmt><authority>ISTEX</authority>
<publisher scheme="https://scientific-publisher.data.istex.fr">ELSEVIER</publisher>
<availability><licence><p>elsevier</p>
</licence>
</availability>
<p scheme="https://loaded-corpus.data.istex.fr/ark:/67375/XBH-HKKZVM7B-M"></p>
<date>1978</date>
</publicationStmt>
<notesStmt><note type="research-article" scheme="https://content-type.data.istex.fr/ark:/67375/XTP-1JC4F85T-7">research-article</note>
<note type="journal" scheme="https://publication-type.data.istex.fr/ark:/67375/JMC-0GLKJH51-B">journal</note>
</notesStmt>
<sourceDesc><biblStruct type="inbook"><analytic><title level="a">POST-THYROIDECTOMY THYROTOXICOSIS</title>
<author xml:id="author-0000"><persName><forename type="first">W.J.</forename>
<surname>Kalk</surname>
</persName>
<affiliation>Departments of Medicine, Radiotherapy, and Nuclear Medicine, University of the Witwatersrand and Johannesburg Hospital, Johannesburg, South Africa</affiliation>
</author>
<author xml:id="author-0001"><persName><forename type="first">Shirley</forename>
<surname>Kantor</surname>
</persName>
<affiliation>Departments of Medicine, Radiotherapy, and Nuclear Medicine, University of the Witwatersrand and Johannesburg Hospital, Johannesburg, South Africa</affiliation>
</author>
<author xml:id="author-0002"><persName><forename type="first">D.</forename>
<surname>Durbach</surname>
</persName>
<affiliation>Departments of Medicine, Radiotherapy, and Nuclear Medicine, University of the Witwatersrand and Johannesburg Hospital, Johannesburg, South Africa</affiliation>
</author>
<author xml:id="author-0003"><persName><forename type="first">J.</forename>
<surname>Levin</surname>
</persName>
<affiliation>Departments of Medicine, Radiotherapy, and Nuclear Medicine, University of the Witwatersrand and Johannesburg Hospital, Johannesburg, South Africa</affiliation>
</author>
<idno type="istex">7EB41D1F2A9F1C85E627B44432FA893096270488</idno>
<idno type="ark">ark:/67375/6H6-M3NQZ9WX-2</idno>
<idno type="DOI">10.1016/S0140-6736(78)90067-3</idno>
<idno type="PII">S0140-6736(78)90067-3</idno>
</analytic>
<monogr><title level="j">The Lancet</title>
<title level="j" type="abbrev">LANCET</title>
<idno type="pISSN">0140-6736</idno>
<idno type="PII">S0140-6736(00)X2692-X</idno>
<imprint><publisher>ELSEVIER</publisher>
<date type="published" when="1978"></date>
<biblScope unit="volume">311</biblScope>
<biblScope unit="issue">8059</biblScope>
<biblScope unit="page" from="291">291</biblScope>
<biblScope unit="page" to="294">294</biblScope>
</imprint>
</monogr>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><creation><date>1978</date>
</creation>
<langUsage><language ident="en">en</language>
</langUsage>
<abstract xml:lang="en"><p>Abstract: 94 patients with postoperative recurrent hyperthyroidism were evaluated for duration of remission, goitre size, and response to radio-iodine (131I). 6 patients required 131I therapy within twelve months of operation—5 had large remnants because of inadequate surgery. 57% of patients relapsed within 5 years, but 16% relapsed after 20 years and 8% after more than 30 years. Estimated goitre weights ranged from 4 g to 65 g, and goitre size was unrelated to the duration of remission. All patients were treated with 131I. 23% of the patients became hypothyroid in the first postoperative year and 10% in the second year. The results indicate that postoperative thyrotoxicosis can recur decades after operation. Operation seems to sensitise the thyroid to the early effects of radiation by 131I.</p>
</abstract>
</profileDesc>
<revisionDesc><change when="1978">Published</change>
</revisionDesc>
</teiHeader>
</istex:fulltextTEI>
<json:item><extension>txt</extension>
<original>false</original>
<mimetype>text/plain</mimetype>
<uri>https://api.istex.fr/ark:/67375/6H6-M3NQZ9WX-2/fulltext.txt</uri>
</json:item>
</fulltext>
<metadata><istex:metadataXml wicri:clean="Elsevier, elements deleted: tail"><istex:xmlDeclaration>version="1.0" encoding="utf-8"</istex:xmlDeclaration>
<istex:docType PUBLIC="-//ES//DTD journal article DTD version 4.5.2//EN//XML" URI="art452.dtd" name="istex:docType"></istex:docType>
<istex:document><converted-article version="4.5.2" docsubtype="fla"><item-info><jid>LANCET</jid>
<aid>78900673</aid>
<ce:pii>S0140-6736(78)90067-3</ce:pii>
<ce:doi>10.1016/S0140-6736(78)90067-3</ce:doi>
<ce:copyright type="unknown" year="1978"></ce:copyright>
</item-info>
<head><ce:title>POST-THYROIDECTOMY THYROTOXICOSIS</ce:title>
<ce:author-group><ce:author><ce:given-name>W.J.</ce:given-name>
<ce:surname>Kalk</ce:surname>
</ce:author>
<ce:author><ce:given-name>Shirley</ce:given-name>
<ce:surname>Kantor</ce:surname>
</ce:author>
<ce:author><ce:given-name>D.</ce:given-name>
<ce:surname>Durbach</ce:surname>
</ce:author>
<ce:author><ce:given-name>J.</ce:given-name>
<ce:surname>Levin</ce:surname>
</ce:author>
<ce:affiliation><ce:textfn>Departments of Medicine, Radiotherapy, and Nuclear Medicine, University of the Witwatersrand and Johannesburg Hospital, Johannesburg, South Africa</ce:textfn>
</ce:affiliation>
</ce:author-group>
<ce:abstract><ce:section-title>Abstract</ce:section-title>
<ce:abstract-sec><ce:simple-para>94 patients with postoperative recurrent hyperthyroidism were evaluated for duration of remission, goitre size, and response to radio-iodine (<ce:sup>131</ce:sup>
I). 6 patients required <ce:sup>131</ce:sup>
I therapy within twelve months of operation—5 had large remnants because of inadequate surgery. 57% of patients relapsed within 5 years, but 16% relapsed after 20 years and 8% after more than 30 years. Estimated goitre weights ranged from 4 g to 65 g, and goitre size was unrelated to the duration of remission. All patients were treated with <ce:sup>131</ce:sup>
I. 23% of the patients became hypothyroid in the first postoperative year and 10% in the second year. The results indicate that postoperative thyrotoxicosis can recur decades after operation. Operation seems to sensitise the thyroid to the early effects of radiation by <ce:sup>131</ce:sup>
I.</ce:simple-para>
</ce:abstract-sec>
</ce:abstract>
</head>
</converted-article>
</istex:document>
</istex:metadataXml>
<mods version="3.6"><titleInfo><title>POST-THYROIDECTOMY THYROTOXICOSIS</title>
</titleInfo>
<titleInfo type="alternative" contentType="CDATA"><title>POST-THYROIDECTOMY THYROTOXICOSIS</title>
</titleInfo>
<name type="personal"><namePart type="given">W.J.</namePart>
<namePart type="family">Kalk</namePart>
<affiliation>Departments of Medicine, Radiotherapy, and Nuclear Medicine, University of the Witwatersrand and Johannesburg Hospital, Johannesburg, South Africa</affiliation>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">Shirley</namePart>
<namePart type="family">Kantor</namePart>
<affiliation>Departments of Medicine, Radiotherapy, and Nuclear Medicine, University of the Witwatersrand and Johannesburg Hospital, Johannesburg, South Africa</affiliation>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">D.</namePart>
<namePart type="family">Durbach</namePart>
<affiliation>Departments of Medicine, Radiotherapy, and Nuclear Medicine, University of the Witwatersrand and Johannesburg Hospital, Johannesburg, South Africa</affiliation>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">J.</namePart>
<namePart type="family">Levin</namePart>
<affiliation>Departments of Medicine, Radiotherapy, and Nuclear Medicine, University of the Witwatersrand and Johannesburg Hospital, Johannesburg, South Africa</affiliation>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<typeOfResource>text</typeOfResource>
<genre type="research-article" displayLabel="Full-length article" authority="ISTEX" authorityURI="https://content-type.data.istex.fr" valueURI="https://content-type.data.istex.fr/ark:/67375/XTP-1JC4F85T-7">research-article</genre>
<originInfo><publisher>ELSEVIER</publisher>
<dateIssued encoding="w3cdtf">1978</dateIssued>
<copyrightDate encoding="w3cdtf">1978</copyrightDate>
</originInfo>
<language><languageTerm type="code" authority="iso639-2b">eng</languageTerm>
<languageTerm type="code" authority="rfc3066">en</languageTerm>
</language>
<abstract lang="en">Abstract: 94 patients with postoperative recurrent hyperthyroidism were evaluated for duration of remission, goitre size, and response to radio-iodine (131I). 6 patients required 131I therapy within twelve months of operation—5 had large remnants because of inadequate surgery. 57% of patients relapsed within 5 years, but 16% relapsed after 20 years and 8% after more than 30 years. Estimated goitre weights ranged from 4 g to 65 g, and goitre size was unrelated to the duration of remission. All patients were treated with 131I. 23% of the patients became hypothyroid in the first postoperative year and 10% in the second year. The results indicate that postoperative thyrotoxicosis can recur decades after operation. Operation seems to sensitise the thyroid to the early effects of radiation by 131I.</abstract>
<relatedItem type="host"><titleInfo><title>The Lancet</title>
</titleInfo>
<titleInfo type="abbreviated"><title>LANCET</title>
</titleInfo>
<genre type="journal" authority="ISTEX" authorityURI="https://publication-type.data.istex.fr" valueURI="https://publication-type.data.istex.fr/ark:/67375/JMC-0GLKJH51-B">journal</genre>
<originInfo><publisher>ELSEVIER</publisher>
<dateIssued encoding="w3cdtf">1978</dateIssued>
</originInfo>
<identifier type="ISSN">0140-6736</identifier>
<identifier type="PII">S0140-6736(00)X2692-X</identifier>
<part><date>1978</date>
<detail type="issue"><title>Originally published as Volume 1, Issue 8059</title>
</detail>
<detail type="volume"><number>311</number>
<caption>vol.</caption>
</detail>
<detail type="issue"><number>8059</number>
<caption>no.</caption>
</detail>
<extent unit="issue-pages"><start>291</start>
<end>344</end>
</extent>
<extent unit="pages"><start>291</start>
<end>294</end>
</extent>
</part>
</relatedItem>
<identifier type="istex">7EB41D1F2A9F1C85E627B44432FA893096270488</identifier>
<identifier type="ark">ark:/67375/6H6-M3NQZ9WX-2</identifier>
<identifier type="DOI">10.1016/S0140-6736(78)90067-3</identifier>
<identifier type="PII">S0140-6736(78)90067-3</identifier>
<recordInfo><recordContentSource authority="ISTEX" authorityURI="https://loaded-corpus.data.istex.fr" valueURI="https://loaded-corpus.data.istex.fr/ark:/67375/XBH-HKKZVM7B-M">elsevier</recordContentSource>
</recordInfo>
</mods>
<json:item><extension>json</extension>
<original>false</original>
<mimetype>application/json</mimetype>
<uri>https://api.istex.fr/ark:/67375/6H6-M3NQZ9WX-2/record.json</uri>
</json:item>
</metadata>
<serie></serie>
</istex>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/H2N2V1/Data/Istex/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000E22 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Istex/Corpus/biblio.hfd -nk 000E22 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Sante |area= H2N2V1 |flux= Istex |étape= Corpus |type= RBID |clé= ISTEX:7EB41D1F2A9F1C85E627B44432FA893096270488 |texte= POST-THYROIDECTOMY THYROTOXICOSIS }}
This area was generated with Dilib version V0.6.33. |